Literature DB >> 6316750

Influence of age on outcome in breast carcinoma.

L E Rutqvist, A Wallgren.   

Abstract

The effect of age on outcome was analysed in an unselected series of 1730 breast carcinoma patients reported from Stockholm county to the Swedish Cancer Registry during 1961-1963. The follow-up time was 18 to 21 years. Patients aged less than 50 years at diagnosis fared better than those who were older (p less than 0.05) but the difference was only significant during the period 0-9 years (p less than 0.001). No significant differences in survival were observed between separate age groups when patients in a random sample consisting of 389 cases were divided by histopathologic axillary node status. The main cause of the demonstrated age effect thus seems to have been a more favourable tumour stage distribution among the young patients. It is concluded, however, that a comprehensive analysis of the effect of age on the outcome of breast carcinoma would require a more detailed stage grouping than, in practice, is available in an unselected series of patients from a whole country or region.

Entities:  

Mesh:

Year:  1983        PMID: 6316750     DOI: 10.3109/02841868309134043

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  3 in total

1.  Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer.

Authors:  C Kamby; P S Soerensen
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

2.  The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study.

Authors:  Youssef Bouferraa; Yolla Haibe; Andrea Chedid; Elio Jabra; Maya Charafeddine; Sally Temraz; Deborah Mukherji; Nagi El Saghir; Ali Shamseddine
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

3.  Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?

Authors:  Aleyamma Mathew; Manoj Pandey; Balakrishnan Rajan
Journal:  World J Surg Oncol       Date:  2004-01-22       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.